Proton pump inhibitors in general medicine. Comparison of routine practices with marketing authorization indications
Olivier Levy-Neumand(l'Assurance Maladie), Xavier Roblin(Centre Hospitalier Universitaire de Saint-Étienne), François Carniaux(Centre Hospitalier Universitaire de Grenoble), Aurélie Durand(Centre National de la Recherche Scientifique), Bruno Bonaz(Inserm)
Cited by 11
Related Papers
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Non-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders
|Nutrients|2013|493
Functional intestinal stem cells after Paneth cell ablation induced by the loss of transcription factor Math1 (Atoh1)
|Proceedings of the National Academy of Sciences|2012|309